Jane Street’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding OBIO
Jane Street's OBIO Position: Q3 2026 in Review
Jane Street sold out of Orchestra BioMed (OBIO) in Q3 2026, closing a stake of 15,360 shares — an estimated $73.6K sold.
Jane Street first reported a position in OBIO in Q2 2024 and held it in 7 quarters. The position peaked at $721K in Q4 2025. 93 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.
- Jane Street reported no remaining Orchestra BioMed position as of Q3 2026 after selling out during the quarter.
- Jane Street sold 15,360 Orchestra BioMed shares in Q3 2026, an estimated $73.6K.
- Jane Street first reported a position in Orchestra BioMed in Q2 2024 and held it in 7 quarters.
- Jane Street's Orchestra BioMed position peaked at $721K in Q4 2025.
- 93 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.